Related references
Note: Only part of the references are listed.Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention
Renate M. Hoogeveen et al.
EUROPEAN HEART JOURNAL (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention
Renate M. Hoogeveen et al.
EUROPEAN HEART JOURNAL (2020)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients
Maxime M. Vroegindewey et al.
BIOMARKERS (2019)
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease
Michiel J. Bom et al.
EBIOMEDICINE (2019)
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aaron W. Aday et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
B Cell-Activating Factor Neutralization Aggravates Atherosclerosis
Dimitrios Tsiantoulas et al.
CIRCULATION (2018)
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome A Secondary Analysis of a Randomized Clinical Trial
Brian A. Bergmark et al.
JAMA CARDIOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study
Rohit M. Oemrawsingh et al.
ATHEROSCLEROSIS (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain
Chiara Caselli et al.
ATHEROSCLEROSIS (2015)
Pivotal role for decorin in angiogenesis
Hannu Jarvelainen et al.
MATRIX BIOLOGY (2015)
The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Franziska S. Hoffmann et al.
JOURNAL OF IMMUNOLOGY (2015)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
Jose Tunon et al.
PLOS ONE (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
Wen Cheng et al.
VASCULAR PHARMACOLOGY (2014)
Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation
Saskia C. A. de Jager et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction
Yasmine Zouggari et al.
NATURE MEDICINE (2013)
Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are Independent Risk Predictors of Short-Term Mortality in Patients with Acute Coronary Syndromes
Saskia C. A. de Jager et al.
PLOS ONE (2012)
Clinical relevance of FGF-23 in chronic kidney disease
Sarah Seiler et al.
KIDNEY INTERNATIONAL (2009)
Death receptors and their ligands in atherosclerosis
Mary M. Kavurma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression, regulation and function of trail in atherosclerosis
Mary M. Kavurma et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Prediction of first coronary events with the Framingham score: A systematic review
Klaus Eichler et al.
AMERICAN HEART JOURNAL (2007)
Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice
Ayman Al Haj Zen et al.
ATHEROSCLEROSIS (2006)
Platelets and chemokines in atherosclerosis - Partners in crime
C Weber
CIRCULATION RESEARCH (2005)
Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions
JW Fischer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Differential accumulation of Proteoglycans and hyaluronan in culprit lesions - Insights into plaque erosion
FD Kolodgie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
